Accelerating Recruitment in a Complex Phase III Parkinson’s Disease Trial
Real-World Solutions for Parkinson’s Disease Trial Challenges
Conducting late-phase Parkinson’s disease clinical trials is never simple—especially across multiple countries with tight timelines and complex regulatory hurdles. In this case study, you’ll learn how TFS delivered rapid, full-service CRO support to rescue a time-sensitive neuroscience trial for a U.S.-based sponsor.
In this exclusive case study, you’ll explore how TFS HealthScience supported a neuroscience-focused sponsor through:
- Navigating European regulatory challenges
- Streamlining global trial operations
- Deploying targeted site activation strategies
- Maintaining study momentum under pressure
Whether you’re preparing for a global Parkinson’s trial or searching for a CRO with neuroscience expertise, this case study offers key takeaways for success in today’s research environment.
Learn more about our related services and resources:
Download the Case Study
Explore how TFS HealthScience helped a biotech sponsor exceed enrollment targets in a complex, multinational Phase III Parkinson’s disease trial.
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.
Learn More About Our Neuroscience Expertise
Rare Neurological Disease Trials: Smarter Design with Natural History, External Controls, and Real-World Evidence
Neuroscience Clinical Research Trends in 2025: How Innovative CROs are Shaping the Future of Neurological Trials
